£1.5M
Playfair Capital led the seed investment in Qureight, with backing from Meltwind, Ascension, and Cambridge Angels, to accelerate drug development partnerships.
Qureight
Qureight builds a data platform to track complex diseases and improve clinical trials.
£2.0MTotal raised
Cambridge based data company Qureight develops a platform that structures image and clinical metadata to track complex diseases.
Categories
Team
MT
Muhunthan Thillai
CEO
Muhunthan is the co-founder and chief executive of Qureight, alongside working as an associate professor at the University of East Anglia and a chest physician at Royal Papworth Hospital. He brings extensive clinical and academic experience from roles across the NHS and Imperial College London.
LinkedInAR
Alessandro Ruggiero
Chief Scientific Officer
Alessandro combines clinical experience as a consultant cardio-thoracic radiologist at Papworth Hospital with entrepreneurial background as the co-founder and chief operating officer of Qureight.
LinkedInInvestors
- £1.5M
- £500KCVCMS VenturesLead
Funding history
£500K
CMS Ventures has backed the Cambridge clinical analytics start-up in its latest funding round.